Lucid Diagnostics Files 8-K
Ticker: LUCD · Form: 8-K · Filed: Feb 25, 2025 · CIK: 1799011
Sentiment: neutral
Topics: 8-K, disclosure, medical-instruments
TL;DR
Lucid Diagnostics filed an 8-K on Feb 25 for an event on Feb 24.
AI Summary
Lucid Diagnostics Inc. filed an 8-K on February 25, 2025, reporting an event that occurred on February 24, 2025. The filing is categorized under 'Other Events' and includes 'Financial Statements and Exhibits'. The company's principal executive offices are located at 360 Madison Avenue, New York, NY.
Why It Matters
This 8-K filing indicates a material event or change for Lucid Diagnostics Inc., requiring disclosure to investors and the public.
Risk Assessment
Risk Level: low — This filing is a standard disclosure form (8-K) and does not inherently indicate significant risk without further context on the 'Other Events' or exhibits.
Key Players & Entities
- Lucid Diagnostics Inc. (company) — Registrant
- February 24, 2025 (date) — Date of earliest event reported
- February 25, 2025 (date) — Filing Date
- 360 Madison Avenue, 25th Floor, New York, NY 10017 (location) — Principal Executive Offices
FAQ
What specific event occurred on February 24, 2025, that necessitated this 8-K filing?
The filing is categorized under 'Other Events' and includes 'Financial Statements and Exhibits', but the specific event is not detailed in the provided text.
What is the primary business of Lucid Diagnostics Inc. according to the filing?
Lucid Diagnostics Inc. is classified under 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]'.
Where are Lucid Diagnostics Inc.'s principal executive offices located?
The principal executive offices are located at 360 Madison Avenue, 25th Floor, New York, NY 10017.
What is the SEC file number for Lucid Diagnostics Inc.?
The SEC file number for Lucid Diagnostics Inc. is 001-40901.
When is the fiscal year end for Lucid Diagnostics Inc.?
The fiscal year end for Lucid Diagnostics Inc. is December 31 (1231).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 25, 2025 regarding Lucid Diagnostics Inc. (LUCD).